AstraZeneca Research Assistant unifies eight biomedical data sources in LLM agent for R&D queries

The system offers a fast direct-answer mode and a multi-step reasoning mode for complex tasks. Responses link every claim to source documents, allowing verification. Deployment covers day-to-day workflows for scientists and clinicians inside AstraZeneca, with architecture choices that prioritize evidence retrieval over generation.

The arXiv technical note (2608.12395) reports integration of eight distinct data modalities without external API calls for internal datasets. This exceeds typical single-corpus RAG setups used by peers such as Merck’s AIDDISON or Pfizer’s internal pilots. Grounding reduces hallucination risk but increases latency in multi-step traces, a documented trade-off.

Operationally the tool shortens literature and trial scouting cycles from days to minutes while maintaining audit trails required for regulatory documentation. Future scaling will depend on whether retrieval precision holds when query volume grows tenfold and when the system begins feeding directly into target-selection dashboards.

Next steps include tighter coupling to high-throughput assay results and potential extension to external collaborators under controlled access. Success metrics will be measured by internal publication citations and time saved per project milestone rather than public benchmarks.